IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies

Cancer vaccination drives the generation of anti-tumor T cell immunity and can be enhanced by the inclusion of effective immune adjuvants such as type I interferons (IFNs). Whilst type I IFNs have been shown to promote cross-priming of T cells, the role of individual subtypes remains unclear. Here w...

Descripción completa

Detalles Bibliográficos
Autores principales: Audsley, Katherine M., Wagner, Teagan, Ta, Clara, Newnes, Hannah V., Buzzai, Anthony C., Barnes, Samantha A., Wylie, Ben, Armitage, Jesse, Kaisho, Tsuneyasu, Bosco, Anthony, McDonnell, Alison, Cruickshank, Mark, Fear, Vanessa S., Foley, Bree, Waithman, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450325/
https://www.ncbi.nlm.nih.gov/pubmed/34552594
http://dx.doi.org/10.3389/fimmu.2021.735133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450325/
https://www.ncbi.nlm.nih.gov/pubmed/34552594
http://dx.doi.org/10.3389/fimmu.2021.735133

Ejemplares similares